Literature DB >> 31790030

Resurgence of measles in the United States: how did we get here?

Kristen A Feemster1,2, Claire Szipszky1.   

Abstract

PURPOSE OF REVIEW: In September 2019, the United States was at risk of losing measles elimination status due to several large-scale outbreaks resulting in more than 1200 confirmed cases across 31 states. This resurgence caps approximately 10 years of increasing incidence, marked by a highly publicized outbreak in 2015 associated with Disneyland when an infected traveler from the Philippines unknowingly spread the virus to susceptible park visitors and the recently ended large outbreak in undervaccinated Orthodox Jewish communities in New York City and Rockland counties. This review highlights current literature elucidating factors associated with current trends in measles epidemiology in the United States, the public health implications of current measles outbreaks and a path forward for addressing challenges contributing to the resurgence of measles in the United States and globally. RECENT FINDINGS AND
SUMMARY: As the most highly transmissible vaccine preventable disease, measles is especially sensitive to changes in herd immunity, the impact of vaccine refusal and globalization. Results highlight the confluence of these factors in current outbreaks, provide tools to predict outbreak risk, demonstrate the growing impact of misinformation and evaluate the impact of policy approaches for outbreak control and prevention.

Mesh:

Substances:

Year:  2020        PMID: 31790030     DOI: 10.1097/MOP.0000000000000845

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  7 in total

1.  Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII.

Authors:  Barbara J Kuter; Gary S Marshall; Jaime Fergie; Elvira Schmidt; Manjiri Pawaskar
Journal:  Hum Vaccin Immunother       Date:  2022-02-07       Impact factor: 3.452

2.  A systematic literature review to clarify the concept of vaccine hesitancy.

Authors:  Daphne Bussink-Voorend; Jeannine L A Hautvast; Lisa Vandeberg; Olga Visser; Marlies E J L Hulscher
Journal:  Nat Hum Behav       Date:  2022-08-22

3.  A model-based opinion dynamics approach to tackle vaccine hesitancy.

Authors:  Camilla Ancona; Francesco Lo Iudice; Franco Garofalo; Pietro De Lellis
Journal:  Sci Rep       Date:  2022-07-12       Impact factor: 4.996

4.  The measles outbreak in Israel in 2018-19: lessons for COVID-19 pandemic.

Authors:  Chen Stein-Zamir; Hagai Levine
Journal:  Hum Vaccin Immunother       Date:  2021-01-22       Impact factor: 3.452

Review 5.  Challenges and Issues of Anti-SARS-CoV-2 Vaccines.

Authors:  Sophie Blumental; Patrice Debré
Journal:  Front Med (Lausanne)       Date:  2021-05-14

6.  COVID-19 Misinformation Trends in Australia: Prospective Longitudinal National Survey.

Authors:  Kristen Pickles; Erin Cvejic; Brooke Nickel; Tessa Copp; Carissa Bonner; Julie Leask; Julie Ayre; Carys Batcup; Samuel Cornell; Thomas Dakin; Rachael H Dodd; Jennifer M J Isautier; Kirsten J McCaffery
Journal:  J Med Internet Res       Date:  2021-01-07       Impact factor: 5.428

7.  Identifying Missed Opportunities for Routine Vaccination among People Who Use Drugs.

Authors:  Paula M Frew; Jay T Schamel; Laura A Randall; Adrian R King; Ian W Holloway; Katherine Burris; Anne C Spaulding
Journal:  Int J Environ Res Public Health       Date:  2021-02-04       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.